Abstract |
The use of afala in patients with benign prostatic hyperplasia and moderate urination disturbances reduced the symptoms of the disease, improved urodynamic parameters, and increased quality of life. Clinical efficiency of afala was comparable with the efficiency of Serenoa repens extract (reference preparation).
|
Authors | K V Savel'eva, M V Kachanova, V N Pavlov, R A Kazikhinurov, M Yu Frolov, A B Mukhin, V V Udut, Z A Yurmazov, Yu L Dugina, S A Sergeeva, O I Epshtein |
Journal | Bulletin of experimental biology and medicine
(Bull Exp Biol Med)
Vol. 148
Issue 2
Pg. 305-7
(Aug 2009)
ISSN: 1573-8221 [Electronic] United States |
PMID | 20027354
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Antibodies
- Immunologic Factors
- afala
|
Topics |
- Adult
- Aged
- Antibodies
(adverse effects, pharmacology, therapeutic use)
- Humans
- Immunologic Factors
(pharmacology, therapeutic use)
- Male
- Middle Aged
- Prostatic Hyperplasia
(drug therapy, pathology)
- Quality of Life
- Treatment Outcome
- Urodynamics
(drug effects)
|